-
Analyst Opinions
NewMobile World Congress (MWC) 2024 – Startups Race for Digital Change
Mobile World Congress (MWC) 2024 Report Overview MWC (Mobile World Congress) is a premier global event for the mobile technology industry, while 4YFN (4 Years from Now) is its associated platform focusing on connecting startups with investors and partners to drive innovation. With over 40 companies in attendance, AI startups took center stage at MWC 2024, signaling robust investor and market interest in AI as the key driver for future innovation. Beyond AI, fintech, digitalization, IoT, digital media, and health...
-
Thematic Analysis
Drones in Power – Thematic Intelligence
Drones in Power Thematic Report Overview The rise in investments and innovations has led to a surge in the popularity of drones. Although historically linked with the military, consumers, and enterprises, this innovative technology is now expanding its reach into the power utilities sector. Technological advancements such as artificial intelligence (AI) and the Internet of Things (IoT) have paved the way for numerous drone applications. Additionally, the increasing trend of drones equipped with light detection and ranging (LiDAR) technology has...
-
Analyst Opinions
NewNew Prescription – Generative AI Meets Healthcare (Vol. 2)
Generative Artificial Intelligence (AI) in Healthcare Report Overview GenAI is generating considerable buzz within the healthcare sector, from news updates to deal negotiations and company filings primarily to drive down costs and optimize administrative workflows, promising better healthcare. From accelerating R&D to easing administrative tasks and creating personalized patient experiences, genAI innovations have now proliferated across all the major healthcare application areas. The ’Generative Artificial Intelligence (AI) in Healthcare’ research report is a compendium of the latest real-world innovations in...
-
Thematic Analysis
Social Media in Banking – Thematic Intelligence
Social Media in Banking Thematic Report Overview Social media companies will increasingly diversify away from their ad-funded business model in the face of increased regulatory scrutiny. Social media in banking thematic report maps out the prospects of social media giants for a deep assault on financial services, and how incumbent banks might respond. The report shares findings from GlobalData’s 2023 Financial Services Consumer Survey, which covers consumer openness to a wide variety of different types of financial services from different...
-
Company Insights
NewPing An Insurance (Group) Company of China – Digital Transformation Strategies
Ping An Digital Transformation Strategies Overview Ping An is tapping into the power of artificial intelligence (AI) to improve its business efficiency. AI, big data, cloud, and blockchain are among the key technologies under focus for the company. The annual ICT spending of Ping An was estimated at $2.8 billion in 2023. A major share of this spending is earmarked for acquiring software, network and communications, and hardware from vendors. Ping An Insurance (Group) Company of China (Ping An) is...
-
Product Insights
Electrophysiology Ablation Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Electrophysiology Ablation Catheters Pipeline Market Report Overview Electrophysiology ablation is applicable for a wide variety of arrhythmias and has an extremely high success rate with low rates of complication and recurrence. The electrophysiology ablation catheters pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GSK-5101955A in Streptococcal Pneumonia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GSK-5101955A in Streptococcal Pneumonia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GSK-5101955A in Streptococcal Pneumonia Drug Details: GSK-5101955A (ASP-3772) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BDTX-1535 in Glioblastoma Multiforme (GBM)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BDTX-1535 in Glioblastoma Multiforme (GBM) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BDTX-1535 in Glioblastoma Multiforme (GBM) Drug Details: BDTX-1535 is under development...
-
Company Insights
NewCaixaBank SA – Digital Transformation Strategies
CaixaBank SA Digital Transformation Strategies Overview CaixaBank is exploring the use of advanced technologies such as blockchain, artificial intelligence, big data, and robotics to increase its operational flexibility and efficiency. AI, big data, cloud, and blockchain are among the key technologies under focus for the company. The annual ICT spending of CaixaBank was estimated at $1.5 billion in 2023. A major share of this spending is earmarked for acquiring software, ICT services, and network and communications from vendors. CaixaBank SA...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BDTX-1535 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BDTX-1535 in Non-Small Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BDTX-1535 in Non-Small Cell Lung Cancer Drug Details: BDTX-1535...